Functional and antigenic concentrations of alpha-1-proteinase inhibitor after administration for the prevention of chronic lung disease of prematurity.
Divisions of Clinical Pharmacology and Toxicology, Genetics, Neonatology, Cardiology, and The Research Institute, The Hospital for Sick Children, Toronto, Ont., Canada.